Altman Lab

Introduction

Amongst other projects, our lab works within 3 groups, funded by the National Institute of Allergy and Infectious Diseases (NIAID):

  • The National Institutes of Health: the Inner-City Asthma Consortium (ICAC) 
  • The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) 
  • The Immune Tolerance Network (ITN)
  • the Allergic Diseases Cooperative Research Centers

In studies with these collaborators, we use network analysis techniques such as cell-deconvolution and modular analysis to reduce the dimensionality of complex data, while simultaneously focusing on the salient elements of the immune response (Chaussabel, Baldwin 2014Obermoster et al 2013Li et al 2014). Collaborations like these help understand complex diseases while laying the groundwork for the discovery of new treatment approaches.

Genome transcriptional profiling and genome sequencing technologies are powerful approaches to identify novel biomarkers and mechanisms of immune mediated diseases. These technologies generate huge amounts of biological information and require sophisticated computational tools to understand molecular pathways of the immune system in health and disease.

Much of the lab's work focuses on molecular profiling of human respiratory samples collected during flares of disease, such as asthma exacerbations, respiratory infections, and allergic reactions. Furthermore, the group's work seeks to both develop and understand personalized approaches to the use of immune based therapeutics in these diseases. 

Matt Altman
Affiliate Investigator

Matthew C Altman, MD, MPhil

Affiliate Investigator; Principal Investigator, Altman Lab; Center for Systems Immunology
View Full Bio

Lab Members

Basilin Benson

Basilin Benson

Bioinformatician, Bioinformatics; Center for Systems Immunology
Naresh Jayavelu

Naresh Doni Jayavelu

Bioinformatician, Bioinformatics; Center for Systems Immunology
Tomasz Janczyk

Tomasz Janczyk

Bioinformatician, Bioinformatics; Center for Systems Immunology
Full-width - Logo HCP Live

Dr. Altman's Interview at AAAAI

During a segment of his HCPLive interview, Matthew Altman, MD, discussed his presentation on systems biology given at the 2023 AAAI Annual Meeting in San Antonio, TX.
Watch the Video

Related Stories

Blog Main Image - Man Coding Single Screen
June 30, 2023

Big Data Reveals Surprising Defense Against COVID-19

“If you’d asked me in March 2020, I’d have said the pandemic was going to be really bad for my asthma patients. But we saw the opposite,” says Matt Altman, MD, MPhil, who treats patients with allergies and asthma at UW Medicine and conducts research at BRI.
Read Article
Blog Main Image - Microscope Sample Dark
December 14, 2022

Immunology to Change Lives: Where We're Going in 2023

BRI was formed with a clear plan: First, answer key fundamental questions about the immune system. Then, build on those answers to change lives. This is a very exciting time because we’re reaching that second stage of the plan.

Read Article
Blog Main Image - 3D Biological Coronavirus Blue Green
June 17, 2022

$11.4 Million to Explore Link Between Viruses and Immune System Diseases

Understanding how viruses impact the immune system has long been a focus at BRI. Two years of pandemic life have made answering two questions particularly important: Can respiratory viruses like the common cold or COVID-19 start the chain reaction that leads to immune system disease?

Read Article

News

News Lancet Planetary Health

NIH study links specific outdoor air pollutants to asthma attacks in urban children

Read More
News UW Medicine

New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids

Read More
News Geek Wire

Studies on respiratory infections, type 1 diabetes, boosted with $17M to Benaroya Research Institute

Read more ➡